Kinnate Biopharma Inc

NASDAQ:KNTE   3:59:55 PM EDT
8.17
-0.88 (-9.72%)
Earnings Announcements

Kinnate Biopharma Reports Full Year 2021 Financial Results And Provides Operational Updates

Published: 03/28/2022 20:20 GMT
Kinnate Biopharma Inc (KNTE) - Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates.
Kinnate Biopharma - As of December 31, 2021, Total of Cash & Cash Equivalents and Short-term Investments $324.9 Million, Exclusive of Joint Venture's Cash.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.